Variant · Snv
STAT2 NM_005419.4(STAT2):c.1257+6A>G
CI-VAR-00196260Explore in graph →NM_005419.4:c.1257+6A>GClinVar 1167213 rs2020854
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1167213 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection; Uveal melanoma; Uterine carcinosarcoma; Malignant lymphoma, large B-cell, diffuse; Hepatocellular carcinoma | germline | 5 | Feb 04, 2026 | clinvar |